Reporting a Price Increase
Pharmaceutical manufacturers with United States Food and Drug Administration-approved prescription drugs sold in or into Texas are required to report prescription drug price increases if the WAC price is $100 or greater for a one-month supply if the price increases more than 15 percent in comparison to the lowest WAC from the last calendar year or increased more than 40 percent in comparison to the lowest WAC from the previous three calendar years.
There are two reporting requirements associated with price increases:
- The Price Increase Report
- The Manufacturer Activity Report
Both reports are due within 30-days of the price effective date.
Reporting Annual WAC
The annual wholesale acquisition cost (WAC) information is submitted here. The January 1, 2020, wholesale acquisition cost (WAC) information on all United States Food and Drug Administration-approved prescription drugs sold in or into Texas from pharmaceutical drug manufacturers is now complete.
The template for submitting year 2021 information will be available by December 15, 2020, and submissions will be accepted between January 1, 2021, to January 15, 2021. Pharmaceutical manufacturers must submit the January 1, 2021, WAC price for all pharmaceutical drugs sold in or into Texas by January 15, 2021.